Versant Capital Management, Inc Genmab A/S Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Genmab A/S stock. As of the latest transaction made, Versant Capital Management, Inc holds 10,567 shares of GMAB stock, worth $228,035. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,567
Previous 8,724
21.13%
Holding current value
$228,035
Previous $170,000
28.24%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
66.2MCall Options Held
729KPut Options Held
398K-
Alliancebernstein L.P. New York, NY14.7MShares$318 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D05.71MShares$123 Million0.8% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$110 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.43MShares$95.5 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$62.2 Million0.45% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.2B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...